Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABBISKO-B

18.130
+1.0406.09%
Volume:4.28M
Turnover:77.40M
Market Cap:12.18B
PE:371.89
High:18.600
Open:17.230
Low:17.230
Close:17.090
52wk High:18.920
52wk Low:2.850
Shares:672.00M
HK Float Shares:672.00M
Volume Ratio:0.66
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.049
ROE:6.88%
ROA:2.27%
PB:5.02
PE(LYR):371.89
PS:18.03

Loading ...

Company Profile

Company Name:
ABBISKO-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
- -
Office Location:
Building 3,No. 898 Halei Road,Zhangjiang Hi-Tech Park,Pudong New Area,Shanghai,China
Zip Code:
- -
Fax:
- -
Introduction:
Abbisko Cayman Ltd is a research and development-driven, clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The Company's clinical-stage drug candidates include ABSK011 inhibitors, ABSK091 inhibitors, ABSK021 inhibitors and ABSK081 antagonists. The Company's selective preclinical stage drug candidates include ABSK043 inhibitors, ABSK061 inhibitors, ABSK121 inhibitors, ABSK012 inhibitors, ABSK111 inhibitors, ABSK071 inhibitors, ABSK051 inhibitors, and ABSK031 antagonists.

Directors

Name
Position
XU Yao Chang
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
YU Hong Ping
Executive Director
JI Jing
Executive Director
SUN Hong Bin
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
SUN Piao Yang
Independent Director,Audit Committee Member
XU Hai Yin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member

Shareholders

Name
Position
XU Yao Chang
CEO
ZHANG Zhen
Vice General Manager,Other Senior Executives
ZHANG Zi Dong
CFO
CHEN Yan Hua
Corporate Secretary
YU Hong Ping
Corporate Secretary,Chief Science Officer,Other Senior Executives
JI Jing
Other Senior Executives
TIAN Hui Min
Other Senior Executives
LI Yong Yi
Advisor